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Decision-making based on reliable evidence is more likely to lead to effective and efficient treatments. Evidence-based
dentistry was developed, similarly to evidence-based medicine, to help clinicians apply current and valid research findings
into their own clinical practice. Interpreting and appraising the literature is fundamental and involves the development of
evidence-based dentistry (EBD) skills. Systematic reviews (SRs) of randomized controlled trials (RCTs) are considered to be
evidence of the highest level in evaluating the effectiveness of interventions. Furthermore, the assessment of the report of
a RCT, as well as a SR, can lead to an estimation of how the study was designed and conducted.
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Introduction
We live in the age of information, innovation, and change.
The number of published studies in the dental literature in-
creases dramatically every year. Clinicians are required to
base their decisions on the best available research evidence
by critically appraising and incorporating sound scientific
evidence into everyday clinical practice [1]. The clinicians'
difficulty of staying current can be facilitated by integrating
basic skills of evidence-based dentistry (EBD), such as the
ability to identify and critically appraise evidence, into
everyday practice [2].Defining evidence-based dentistry
The practice of evidence-based dentistry consists in den-
tists critically applying relevant research findings to the
care of patients [3]. The American Dental Association
(A.D.A.) defines evidence-based dentistry as ‘an approach
to oral health care that requires the judicious integration of
systematic assessments of clinically relevant scientific evi-
dence, relating to the patient's oral and medical condition
and history, with the dentist's clinical expertise and the
patient's treatment needs and preferences.’ Evidence-based* Correspondence: argy_poly@post.harvard.edu
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in any medium, provided the original work is pdentistry is based on three important domains: the best
available scientific evidence, dentist's clinical skills and judg-
ment, and patient's needs and preferences. Only when all
three are given due consideration in individual patient care
is EBD actually being practiced [4].
Why is evidence-based dentistry important?
Practicing evidence-based dentistry reassures the quality
improvement of health-care delivery by incorporating ef-
fective practices, while eliminating those that are inef-
fective or inappropriate [5]. The main advantage of EBD
is that, in fact, it uses significant findings obtained from
large clinical trials and systematic reviews and applies
them to the individual patient's needs. In this way, clini-
cians are able to deliver more focused treatment, while
patients receive optimal care [6].
The five steps of evidence-based dentistry practice
The practice of EBD involves five essential steps [4,7,8]:
1. Developing a clear, clinically focused question
2. Identifying, summarizing, and synthesizing all
relevant studies that directly answer the formulated
question
3. Appraising evidence in terms of validity and
applicabilityan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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and patients characteristics
5. Assessing the successful implementation of
previous steps
Choosing the best form of evidence
Some research designs are more effective than others
in their ability to answer specific research questions.
Rules of evidence have been established to grade evi-
dence according to its strength, giving rise to the con-
cept of ‘hierarchy of evidence.’ The hierarchy provides
a framework for rating evidence and indicates which
study types should be given more weight when asses-
sing the same question [9]. At the top of the hierarchy,
we find high-quality systematic reviews of randomized
controlled trials, with or without meta-analysis together
with randomized controlled trials (RCTs) of very low
risk of bias (Table 1) [10].
Classification of studies based on research design
Clinical research can be either observational or experi-
mental. In observational studies, the investigator ob-
serves patients at a point in time or over time, without
intervening. They may be cross-sectional, providing a
snapshot picture of a population at a particular point
in time, or longitudinal, following the individuals over
a period of time. Observational studies may also be
prospective, when the data are collected forward in
time from the beginning of the study, or retrospective,
in which the information is obtained by going back-
wards in time [11,12].
The most common types of observational studies are:Table 1 Revised grading system for recommendations in
evidence-based guidelines [10]
Levels of evidence
1++ High-quality meta-analyses, systematic reviews
of RCTs, or RCTs with a very low risk of bias
1+ Well-conducted meta-analyses, systematic reviews
of RCTs, or RCTs with a low risk of bias
1− Meta-analyses, systematic reviews or RCTs,
or RCTs with a high risk of bias
2++ High-quality systematic reviews of case-control
or cohort studies or high-quality case-control or
cohort studies with a very low risk of confounding,
bias, or chance and a high probability that the
relationship is causal
2+ Well-conducted case-control or cohort studies with
a low risk of confounding, bias, or chance and a
moderate probability that the relationship is causal
2− Case-control or cohort studies with a high risk
of confounding, bias, or chance and a significant
risk that the relationship is not causal
3 Non-analytic studies, e.g., case reports, case series
4 Expert opinion Cohort studies
In a cohort study, people are divided into cohorts,
based on whether they have been exposed or not to
a treatment, and then they are followed over a
period of time to note the occurrence of an event,
or not [11].
 Case-control studies
In a case-control study, a sample of cases is
compared with a group of controls who do not have
the outcome of interest. The cases and controls are
then categorized according to whether or not they
have been exposed to the risk factor [12].
 Cross-sectional studies
Cross-sectional studies attempt to investigate an
association between a possible risk factor and a
condition. The data concerning the exposure to the
causal agent and outcome are collected
simultaneously [13].
 Case reports and case series
A case report is a descriptive report of a single
patient. A case series is a descriptive report on a
series of patients with a condition of interest. No
control group is involved [14].
Experimental is the type of study in which the
investigator intervenes so as to observe the effect on
the outcome being studied [12]. Experimental
studies can be either controlled (a comparison group
exists) or uncontrolled. Sutherland [11] suggests
that uncontrolled studies provide very weak evidence
and should not be used as a reference for decision-
making. Studies with experimental design can be
distinguished in those where the comparisons are
made between subjects (parallel groups design) or
within subjects (matched design or cross-over or
split-mouth studies). The clinical trial is a particular
form of experimental study performed on humans
[12]. A well-designed trial involves a comparison
between groups formed after the randomization of
patients to treatments. This type of study is called a
randomized controlled clinical trial (RCT) [15].
The randomized controlled clinical trial
The randomized controlled clinical trial is a specific type of
scientific experiment which is characterized by several dis-
tinguishing features. A fundamental feature of a clinical
trial is that it is comparative in nature. This means that the
results of a group of patients who are receiving the treat-
ment under investigation (treatment group) are compared
with those of another group of patients with similar char-
acteristics who are not receiving the particular treatment
(control group) [15]. In the RCT, the participants are ran-
domly assigned to either experimental or control groups in
a way that each participant has an equal probability of be-
ing assigned to any given group (randomization) [16]. As
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ing compared, any differences in outcomes are attributed
to the intervention [17].
An essential issue of a RCT is the concealment of the
allocation sequence from the investigators who assign
participants to treatment groups (allocation conceal-
ment). Allocation concealment should not be confused,
though, with blinding, which corresponds to whether pa-
tients and investigators know or do not know which
treatment they received [18]. Even though the validity of
a RCT depends mainly on the randomization procedure,
it is almost inevitable that after randomization some par-
ticipants would not complete the study [19]. Intention-
to-treat (ITT) analysis is a strategy that ensures that all
patients are included in the analysis as part of the groups
they were originally randomized, regardless of whether
they withdrew or did not receive the treatment. Applica-
tion of true ITT analysis requires some assumptions and
some form of imputations for the missing data [20,21].
The RCT is the most scientifically rigorous method of
hypothesis testing available [20] and is regarded as the gold
standard trial for evaluating the effectiveness of interven-
tions [17]. The RCT is the only study which allows investi-
gators to balance unknown prognostic factors at baseline
(selection bias), this being its main advantage. Random al-
location does not, however, protect RCTs against other
types of bias (Table 2) [21]. Bias refers to the systematic
(not random) deviation from the truth [22].
Most randomized controlled clinical trials have parallel
designs in which each group of participants is exposed to
only one of the interventions of interest (Figure 1) [23].
Understanding systematic reviews
It is well recognized that health-care decisions should
not be based merely on one or two studies but take into
consideration all the scientific research available on a
specific topic [24]. Still, applying research into practice
may be time consuming as it is often impractical for
readers to track down and review all of the primary
studies [2,25]. Systematic reviews are particularly useful
in synthesizing studies, even those with conflicting find-
ings [24]. A systematic review is a form of research thatTable 2 Classification scheme of bias in RCTs [22]
Type of bias Prevention/elimination of bias
▪ Selection bias Proper randomization
▪ Performance bias Blinding of participants and people
administering treatment
▪ Detection bias Blinding of outcome assessors/analyzers
▪ Attrition bias Blinding participants, intention-to-treat analysis
▪ Publication bias Trial registration, no selective reporting
▪ Other biases No selective reporting, meticulous study designuses explicit methods to identify comprehensively all stud-
ies for a specific focused question, critically appraise them,
and synthesize the world literature systematically [26-28].
The explicit methods used in systematic reviews limit bias
and, hopefully, will improve reliability and accuracy of
conclusions [29].
Developing a systematic review requires a number of
discrete steps [22]:
1. Defining an appropriate health-care question
2. Searching the literature
3. Assessing the selected studies
4. Synthesizing the findings
5. Placing the findings in context
What are Cochrane reviews? Cochrane reviews are sys-
tematic reviews of primary research in human health
care and health policy, undertaken by members of The
Cochrane Collaboration [30] adhering to a specific
methodology [31]. The Cochrane Collaboration is an
international organization that aims to organize medical
research information in a systematic way promoting the
accessibility of systematic reviews of the effects of
health-care interventions [31].
What is a meta-analysis? Frequently, data from all
studies included in a systematic review are pooled quantita-
tively and reanalyzed; this is called a meta-analysis [32].
This technique increases the size of the ‘overall sample’ and
ultimately enhances the statistical power of the analysis
[33]. A meta-analysis can be included in a well-executed
systematic review. Quantitative synthesis should only be
applied under certain conditions such as when the studies
to be combined are clinically and statistically homoge-
neous. If the original review was biased or unsystematic,
then the meta-analysis may provide a false measure of
treatment effect [34].
Principles of critical appraisal
For any clinician, the key to assessing the usefulness of a
clinical study and interpreting the results to a particular
subject is through the process of critical appraisal. Critical
appraisal is an essential skill of evidence-based dentistry
which involves systematic assessment of research allowing,
thus, clinicians to apply valid evidence in an efficient man-
ner. When critically appraising research, there are three
main areas that should be assessed: validity, importance,
and applicability [35].
A study which is sufficiently free from bias is consid-
ered to have internal validity [36]. Common types of
bias that affect internal validity include allocation bias,
blinding, data collection methods, dropouts, etc. [37].
External validity refers to whether the study is asking an
appropriate research question, as well as whether the
Figure 1 Flow diagram of the progress through the phases of a parallel RCT of two groups. Modified from CONSORT 2010 [23].
Kiriakou et al. Progress in Orthodontics 2014, 15:58 Page 4 of 8
http://www.progressinorthodontics.com/content/15/1/58study results reflect what can be expected in the popula-
tion of interest (generalizability) [22].
Appraising a randomized controlled trial
Randomized controlled trials are the standard for test-
ing the efficacy of health-care interventions. The bet-
ter a RCT is designed and conducted, the more likely
it is to provide a true estimate of the effect of an
intervention. When reading a RCT article, we should
focus on certain issues in order to decide whether the
results of the study are reliable and applicable to our
patient [38].
 The validity of the trial methodology
During the process of appraising a RCT, readers
should evaluate the following:
1. Clear, appropriate research question
The clinical question should specify the type of






The concepts of randomization, allocation
concealment, blinding, and ITT analysis were
previously explained.
6. Statistical power
McAlister et al. define the statistical power of a
RCT as ‘the ability of the study to detect adifference between the groups when such a
difference exists’. The size of the sample must be
large enough to raise the trial's possibilities of
answering the research question and, thus,
enhancing the statistical power of the trial [39]. The magnitude and significance of treatment effect
Magnitude refers to the size of the treatment effect.
The effect size represents the degree to which the
two interventions differ. Effect size in RCTs may be
reported in various ways including mean difference,
risk ratio, odds ratio, risk difference, rate and hazard
ratio, and numbers needed to treat [40,41].
Statistical significance refers to the likelihood that a
relationship is caused by something other than
simple random chance. Probability (p) values and
confidence intervals (CI) are used to assess statistical
significance [42]. A statistically significant result
indicates that there is probably a relationship between
the variables of interest, but does not show whether
this is important. Clinical significance refers to the
practical meaning of the effect of an intervention to
patients and health-care providers [43].
 Generalizability of trial results
The fact that evidence addresses the effectiveness of
a treatment does not mean that all patients will
necessarily benefit from that. Thus, a clinician
should always examine the similarities of the study
participants with his own patients together with the
proportion between the benefits and adverse events
of the therapy [38].
Table 3 Items to include when reporting a randomized
trial in a journal or conference abstract [60]
Item Description Reported on
line number
Title Identification of the study
as randomized
Authorsa Contact details for the
corresponding author




Participants Eligibility criteria for participants




Objective Specific objective or hypothesis
Outcome Clearly defined primary
outcome for this report
Randomization How participants were
allocated to interventions
Blinding (masking) Whether or not participants,
caregivers, and those assessing
the outcomes were blinded
to group assignment
Results
Numbers randomized Number of participants
randomized to each group
Recruitment Trial status
Numbers analyzed Number of participants
analyzed in each group
Outcome For the primary outcome,
a result for each group and
the estimated effect size
and its precision
Harms Important adverse
events or side effects
Conclusions General interpretation of the
results
Trial registration Registration number and
name of trial register
Funding Source of funding
aThis item is specific to conference abstracts.
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been proposed for assessing the quality of studies. Most
tools are scales in which various quality elements are
scored or checklists in which specific questions are
asked [44]. One method used to critically appraise ran-
domized trials is the Risk of Bias Tool, developed by The
Cochrane Collaboration, which is based on a critical
evaluation of six different domains [22]. The Critical
Appraisal Skills Program (CASP), also, aims to help
people develop the necessary skills to interpret scien-
tific evidence. CASP has released critical appraisal
checklists for different types of research studies that
cover three main areas of a study: validity, results, and
clinical relevance [45]. Likewise, the Scottish Intercolle-
giate Guidelines Network (SIGN) has developed a meth-
odology checklist in order to facilitate the assessment
of a RCT. This checklist consists of three sections, each
covering key topics of a trial [46].
Tools assessing the reporting quality of RCTs To as-
sess a trial accurately, readers need complete and
transparent information on its methodology and find-
ings. However, the reporting of RCTs is often incom-
plete [45-50] aggravating problems arising from poor
methodology [51-56]. The Consolidated Standards of
Reporting Trials (CONSORT) statement, which is
aimed at trials with a parallel design, consists of a
checklist of essential items that should be included in
the report of a RCT together with a diagram showing
the flow of participants through the phases of the trial.
The objective of CONSORT is to provide guidance to
authors about how to improve the reporting of their
trials. Additionally, it can be used by readers, peer re-
viewers, and editors to help them critically appraise
reports of RCTs [23].
Many clinicians base their assessment of a trial, or
even their clinical decisions, on the information reported
in the abstract, as they only read, or have access to, the
abstracts of journal articles [57]. A well-written and con-
structed abstract should help the readers assess quickly
the validity and applicability of the trial findings [58].
Several studies have accentuated the need for improve-
ment in the reporting of conference abstracts and jour-
nal abstracts of RCTs [59]. The CONSORT for Abstracts
(Table 3) provides a list of essential items that authors
should consider when reporting a randomized trial in
any journal or conference abstract [60].
Appraising systematic reviews and meta-analyses
Simply naming a review systematic does not imply that
it is valid, even though systematic reviews are consid-
ered to be evidence of the highest level in the hierarchy
of studies evaluating the effectiveness of interventions
[10]. Readers need to be sure that the methodology usedto synthesize relevant information was appropriate. This
can be achieved by answering a few critical questions [61]:
1. Did the review have a predetermined protocol?
2. Was the question well formulated?
3. Did the review include appropriate type of studies?
4. Were all relevant studies identified using a
comprehensive method?
5. Were the included studies assessed in terms of
their validity?
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each study?
7. How was the information synthesized and was the
synthesis appropriate?
Tools assessing the quality of systematic reviews and
meta-analyses A tool commonly used to critically ap-
praise the quality of a systematic review (with or without
meta-analysis) is the Assessment of Multiple Systematic
Reviews (AMSTAR) which consists of an 11-item ques-
tionnaire assessing the presence of key methodological
issues [62]. SIGN has developed, as well, different meth-
odology checklists for the most common types of stud-
ies, including systematic reviews. This checklist covers
all main topics of a systematic review (SR) aiming to fa-
cilitate the process of critical appraisal [46].
Tools assessing the reporting quality of systematic
reviews and meta-analyses The Meta-analyses of
Observational Studies in Epidemiology (MOOSE) guide-
lines were designed to promote the reporting quality in re-
views of observational studies [63]. The MOOSE checklist
includes guidelines for the reporting of the background,
search strategies, methods, results, discussion, and conclu-
sion of the study [64]. The Institute of Medicine (IOM) ofTable 4 The PRISMA for Abstracts checklist [68]
Item Description
Title
1. Title Identification of the
Background
2. Objectives The research quest
interventions, comp
Methods
3. Eligibility criteria Study and report c
4. Information sources Key databases sear
5. Risk of bias Methods of assessin
Results
6. Included studies Number and type o
7. Synthesis of results Results for main ou
of studies and part
measures and conf
8. Description of the effect Direction of the eff
in terms meaningfu
Discussion
9. Strengths and limitations of evidence Brief summary of st
(e.g., inconsistency,
other supporting o
10. Interpretation General interpretat
Other
11. Funding Primary source of f
12. Registration Registration numbethe National Academies, also, has developed standards for
conducting systematic reviews in order to help authors
improve the reporting quality of their studies [65]. The
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) Statement focuses on ways in
which authors can ensure the transparent and complete
reporting of systematic reviews and meta-analyses. PRISMA
consists of a checklist of 27 items indispensable in the
reporting of SRs and meta-analyses and a flow diagram il-
lustrating the flow of information through the four differ-
ent phases of a systematic review [66].
The main function of an abstract of a systematic re-
view is to signal its systematic methodology. However,
despite the development of PRISMA, which gave some
guidance for abstracts, the quality of abstracts of system-
atic reviews, as in RCTs, still remained poor [67]. The
PRISMA for Abstracts consists of a 12-item checklist of
items to report when writing an abstract of a SR with or
without meta-analyses (Table 4) [68].
Applying evidence into practice - introducing GRADE
Health-care professionals are urged to inform their clin-
ical decisions with the best relevant evidence. Clinicians,
thus, are expected not only to deliver a treatment but to
choose the best treatment option based on their patients'study as a systematic review, meta-analysis, or both
ion including components such as participants,
arators, and outcomes
haracteristics used as criteria for inclusion
ched and search dates
g risk of bias
f included studies and participants and relevant characteristics of studies
tcomes (benefits and harms), preferably indicating the number
icipants for each. If meta-analysis was done, include summary
idence intervals.
ect (i.e., which group is favored) and size of the effect
l to clinicians and patients
rengths and limitations of evidence
imprecision, indirectness, or risk of bias,
r conflicting evidence)
ion of the results and important implications
unding for the review
r and registry name
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harms. However, translating research findings into clinical
guidelines can often be challenging. Moreover, users of
guidelines need to be confident that they can rely on
existing recommendations. Grading of Recommendations
Assessment, Development and Evaluation (GRADE) is a
system for grading the quality of evidence in order to de-
velop recommendations that are as evidence-based as pos-
sible [69]. The GRADE methodology consists of the
formulation of a clear clinical question which is followed
by the identification of all relevant outcomes from sys-
tematic reviews, rated depending on how important
they are for the development of a recommendation [70].
Judgments about the quality of evidence for important
outcomes are made, and specific recommendations are
formulated based on the strength of evidence and net ben-
efits [69]. GRADE is not only a rating system. It provides a
structured process for developing the strength of recom-
mendations, and its explicit and comprehensive approach
ensures the transparency of the judgments made [71].
Conclusions
Clinical decisions guided by valid and reliable research
findings are considered to be more focused and effective
than others [1]. Evidence indicates that controlled trials
and systematic reviews with inadequate methodology are
more susceptible to bias [6,14]. Optimal reporting of RCT
and SR abstracts is particularly important in enabling in-
creased and sufficient access to evidence. The develop-
ment of standards for the reporting of scientific results is
essential for dissemination of new knowledge [58].
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